{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:25:57Z","timestamp":1751405157108},"reference-count":22,"publisher":"Tokyo Dental College","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull. Tokyo Dent. Coll."],"published-print":{"date-parts":[[2019]]},"DOI":"10.2209\/tdcpublication.2018-0067","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T17:05:03Z","timestamp":1574355903000},"page":"251-260","source":"Crossref","is-referenced-by-count":0,"title":["Ten-year Clinical Trends among 575 Consecutive Oral Cancer Patients at Tokyo Dental College Oral Cancer Center"],"prefix":"10.2209","volume":"60","author":[{"given":"Shoichi","family":"Sekikawa","sequence":"first","affiliation":[{"name":"Oral Cancer Center, Tokyo Dental College"},{"name":"Department of Oral and Maxillofacial Surgery, Tokyo Dental College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Kozakai","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Tokyo Dental College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine, Oral and Maxillofacial Surgery, Tokyo Dental College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homare","family":"Kawachi","sequence":"additional","affiliation":[{"name":"Oral Cancer Center, Tokyo Dental College"},{"name":"Department of Oral Medicine, Oral and Maxillofacial Surgery, Tokyo Dental College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Ogane","sequence":"additional","affiliation":[{"name":"Oral Cancer Center, Tokyo Dental College"},{"name":"Department of Oral and Maxillofacial Surgery, Tokyo Dental College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Takano","sequence":"additional","affiliation":[{"name":"Oral Cancer Center, Tokyo Dental College"},{"name":"Department of Oral and Maxillofacial Surgery, Tokyo Dental College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nomura","sequence":"additional","affiliation":[{"name":"Oral Cancer Center, Tokyo Dental College"},{"name":"Department of Oral Medicine, Oral and Maxillofacial Surgery, Tokyo Dental College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Katakura","sequence":"additional","affiliation":[{"name":"Oral Cancer Center, Tokyo Dental College"},{"name":"Department of Oral Pathobiological Science and Surgery, Tokyo Dental College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Shibahara","sequence":"additional","affiliation":[{"name":"Oral Cancer Center, Tokyo Dental College"},{"name":"Department of Oral and Maxillofacial Surgery, Tokyo Dental College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Takano","sequence":"additional","affiliation":[{"name":"Oral Cancer Center, Tokyo Dental College"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1039","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354: 567\u2013578.","DOI":"10.1056\/NEJMoa053422"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter CJ, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA (2018) Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 36: 1714\u20131768.","DOI":"10.1200\/JCO.2017.77.6385"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68: 394\u2013424.","DOI":"10.3322\/caac.21492"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Chi AC, Day TA, Neville BW (2015) Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Cancer J Clin 65: 401\u2013421.","DOI":"10.3322\/caac.21293"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Chinn SB, Myers JN (2015) Oral cavity carcinoma: current management, controversies, and future directions. J Clin Oncol 33: 3269\u20133276.","DOI":"10.1200\/JCO.2015.61.2929"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Choi SW, Moon EK, Park JY, Jung KW, Oh CM, Kong HJ, Won YJ (2014) Trends in the incidence of and survival rates for oral cavity cancer in the Korean population. Oral Dis 20: 773\u2013779.","DOI":"10.1111\/odi.12251"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ebrahimi A, Zhang WJ, Gao K, Clark JR (2011) Nodal yield and survival in oral squamous cancer: defining the standard of care. Cancer 117: 2917\u20132925.","DOI":"10.1002\/cncr.25834"},{"key":"8","unstructured":"8) Eida S, Sumi M, Yonetsu K, Kimura Y, Nakamura T (2003) Combination of helical CT and doppler sonography in the follow-up of patients with clinical N0 stage neck disease and oral cancer. Am J Neuroradiol 24: 312\u2013318."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ferris RL, Blumenschein GJ, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Geese WJ, Kopit J, Shaw JW, Gillison ML (2016) Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 375: 1856\u20131867.","DOI":"10.1056\/NEJMoa1602252"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kademani D (2007) Oral cancer. Mayo Clin Proc 82: 878\u2013887.","DOI":"10.4065\/82.7.878"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48: 452\u2013458.","DOI":"10.1038\/bmt.2012.244"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kiyota N, Hasegawa Y, Takahashi S, Yokota T, Yen CJ, Iwae S, Shimizu Y, Hong RL, Goto M, Kang JH, Sum Kenneth Li W, Ferris RL, Gillison M, Namba Y, Monga M, Lynch M, Tahara M (2017) A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator&apos;s choice in recurrent squamous cell carcinoma of the head and neck: a subanalysis of Asian patients versus the global population in checkmate 141. Oral Oncol 73: 138\u2013146.","DOI":"10.1016\/j.oraloncology.2017.07.023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) List MA, D&apos;Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E (1996) The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity. Cancer 77: 2294\u20132301.","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S"},{"key":"14","unstructured":"14) National Comprehensive Cancer Network (2018) NCCN Clinical Practice Guidelines in Oncology Head and Neck Cancers version 2.2018. NCCN Head and Neck Cancers Panel Members, https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx (1 December 2018)"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Patel SC, Carpenter WR, Tyree S, Couch ME, Weissler M, Hackman T, Hayes DN, Shores C, Chera BS (2011) Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 29: 1488\u20131494.","DOI":"10.1200\/JCO.2010.31.7883"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Rana M, Kanatas A, Herzberg PY, Khoschdell M, Kokemueller H, Gellrich NC, Rana M (2015) Prospective study of the influence of psychological and medical factors on quality of life and severity of symptoms among patients with oral squamous cell carcinoma. Br J Oral Maxillofac Surg 53: 364\u2013370.","DOI":"10.1016\/j.bjoms.2015.01.019"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Saada-Bouzid E, Defaucheux C, Karabajakian A, Coloma VP, Servois V, Paoletti X, Even C, Fayette J, Guigay J, Loirat D, Peyrade F, Alt M, Gal J, Le Tourneau C (2017) Hyperprogression during anti-PD-1\/PD-L1 therapy in patients with recurrent and\/or metastatic head and neck squamous cell carcinoma. Ann Oncol 28: 1605\u20131611.","DOI":"10.1093\/annonc\/mdx178"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Salem JE, Manouchehri A, Moey M, Lebrun-Vignes B, Bastarache L, Pariente A, Gobert A, Spano JP, Balko JM, Bonaca MP, Roden DM, Johnson DB, Moslehi JJ (2018) Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol 19: 1579\u20131589.","DOI":"10.1016\/S1470-2045(18)30608-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Scully C, Carrozzo M (2008) Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 46: 15\u201321.","DOI":"10.1016\/j.bjoms.2007.07.199"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Shiboski CH, Schmidt BL, Jordan RCK (2005) Tongue and tonsil carcinoma. Cancer 103: 1843\u20131849.","DOI":"10.1002\/cncr.20998"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Suzuki T, Tanaka Y, Sato K, Katakura A (2016) Evaluating the Bethesda system for liquid-based oral cytology. Jpn J Oral Diag\/Oral Med 29: 28\u201335.","DOI":"10.15214\/jsodom.29.28"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol D, Peyrade F, Benasso M, Vynnychenko I, De Raucourt D, Bokemeyer C, Schueler A, Amellal N, Hitt R (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359: 1116\u20131127.","DOI":"10.1056\/NEJMoa0802656"}],"container-title":["The Bulletin of Tokyo Dental College"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tdcpublication\/60\/4\/60_2018-0067\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T23:22:01Z","timestamp":1576279321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tdcpublication\/60\/4\/60_2018-0067\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2209\/tdcpublication.2018-0067","relation":{},"ISSN":["0040-8891"],"issn-type":[{"value":"0040-8891","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}